Rory E. Kim, PharmD, MACM, BCACP
Faculty Directory

Rory E. KimPharmD, MACM, BCACP

Rory E. KimPharmD, MACM, BCACP

Assistant Professor of Clinical Pharmacy

Titus Family Department of Clinical Pharmacy

Rory O’Callaghan Kim is an assistant professor of clinical pharmacy at the USC School of Pharmacy. After receiving her doctorate in pharmacy from the University of Kansas in May 2008, she moved to Los Angeles to pursue her postdoctoral training at USC. She completed a PGY1 Pharmacy Residency in ambulatory care in 2009 and a fellowship in ambulatory care and academia in 2010.

After completion of her postdoctoral training, she accepted a position with USC as a clinical pharmacist implementing comprehensive medication management programs into safety-net clinics in Los Angeles. She was hired as a faculty member at USC in July 2013. She is currently the residency program director for the PGY1 Ambulatory Care residency. She is the course co-coordinator for the Pharmacy Literature Analysis & Drug Information course as well as the Health Care Needs for Special Populations elective. She chairs the PharmD Scholarly Project Committee.

Kim received a master of academic medicine from the Keck School of Medicine of USC in 2018.

Areas of Expertise

  • Hypertension
  • Interprofessional Education
  • Medication Adherence
  • Innovative Teaching Methodologies
  • Ambulatory Care
  • Clinical Pharmacy
  • Ambulatory Care and Academia
  • Comprehensive Medication Management
  • Diabetes
  • Anticoagulation
  • Education

    University of Kansas

    PharmD

    University of Southern California

    MACM

  • Links
  • Selected Articles

    Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings

    Mental Health Clinician
    Rory Kim et al.

    2018 This was a retrospective chart review of patients ≥18 years of age seen in primary care clinics in Los Angeles County with a documented annual health screening (AHS) between January 1, 2015, through December 31, 2015. Primary outcomes were number and percentage of patients screened for depression with patient health questionnaire (PHQ) assessments, positive depression screenings, and interventions made for positive depression screenings. Secondary outcomes were PCPs' perceptions on management of depression, use of AHS, and roles for psychiatric pharmacists through evaluation of provider survey.

    Read More